New information for vaccine manufacturers

A new process came into effect on 1 July 2020 for sponsors to request advice from ATAGI for vaccines to be listed on the National Immunisation Program.

Date published:
Audience:
General public

Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from the Australian Technical Advisory Group on Immunisation (ATAGI) before making a submission to the Pharmaceutical Benefits Advisory Committee (PBAC).

A new process for requesting this advice is now in effect.  

Vaccine manufacturers can contact the ATAGI secretariat with any questions about these arrangements.